CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
Author
Barrie M.
Bijou F.
+22Â more
Blonski M.
Boyle E.
Cassoux N.
Choquet S.
Clavert A.
Coisy S.
Daniau M.
El Yamani A.
Ertault de la Bretonnière M.
Ghesquières H.
Gressin R.
Hoang-Xuan K.
Houillier C.
Houot R.
Leclercq D.
Lelez M.L.
Leruez S.
Moluçon-Chabrot C.
Nicolas-Virelizier E.
Rezai K.
Soussain C.
Touitou V.
Publication venue
'Elsevier BV'
Publication date
01/08/2019
Field of study
No full text
International audienc
HAL-Rennes 1